Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
RegSmart Life Science AB
AB
Active
Org 5592005382
Eklundshovsvägen 5, 752 37
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
11 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
RegSmart Life Science AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
30M
22M
15M
7M
0M
2020: 9M
9M
2020
2021: 15M (+67% vs 2020)
15M
+67%
2021
2022: 23M (+53% vs 2021)
23M
+53%
2022
2023: 20M (-13% vs 2022)
20M
-13%
2023
2024: 24M (+20% vs 2023)
24M
+20%
2024
EBITDA
SEK millions
6M
5M
3M
2M
0M
2020: 2M
2M
2020
2021: 4M (+100% vs 2020)
4M
+100%
2021
2022: 5M (+25% vs 2021)
5M
+25%
2022
2023: 2M (-60% vs 2022)
2M
-60%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
23 522
19 705
23 144
15 200
8 659
Staff expenses
—
—
—
—
—
EBITDA
1 655
2 293
5 072
3 531
1 992
Depreciation & amort.
−43
−34
−28
−0
−0
EBIT
1 612
2 259
5 044
3 531
1 992
Net financials
487
433
1
−15
−6
Profit before tax
42
1 995
3 757
2 630
1 626
Tax
−38
−430
−783
−460
−437
Net profit
4
1 565
2 974
2 170
1 189
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
17 506
16 171
13 445
8 754
4 958
Equity
7 520
7 515
5 950
3 977
1 806
Long-term debt
0
0
0
0
0
Short-term debt
6 757
5 423
4 960
3 531
2 791
Total debt
6 757
5 423
4 960
3 531
2 791
Financial ratios
5-year trend
EBITDA margin
7,0 %
This company
15,8 %
Market median
This company
Market median
56% below market
2020
2024
Equity ratio
43,0 %
This company
38,2 %
Market median
This company
Market median
13% above market
2020
2024
Return on equity
0,1 %
This company
18,4 %
Market median
This company
Market median
99% below market
2020
2024
Net profit margin
0,0 %
This company
8,1 %
Market median
This company
Market median
100% below market
2020
2024
Asset turnover
1,34×
This company
1,12×
Market median
This company
Market median
20% above market
2020
2024
Debt / equity
1,33×
This company
0,62×
Market median
This company
Market median
115% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on RegSmart Life Science AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
